Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

Clinical trial NCT07538583 · RECRUITING

Trial details

NCT number: NCT07538583
Sponsor: Quoin Pharmaceuticals
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Netherton Syndrome

Start date: 2026-03-19
Primary completion: 2027-01-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.